Webb22 apr. 2024 · Endometrial cancer is the most common gynecologic malignancy in the United States and its prevalence is increasing. Approximately 75% of endometrial cancers are diagnosed at an early stage... RUBY is a two-part global, randomised, double-blind, multicentre phase III trial of patients with primary advanced or recurrent endometrial cancer. Part 1 is evaluating dostarlimab plus carboplatin-paclitaxel followed by dostarlimab versus carboplatin-paclitaxel plus placebo followed by placebo.
Endometrial cancer - Diagnosis and treatment - Mayo Clinic
WebbCarboplatin-paclitaxel is standard of care for recurrent/advanced EC for which surgery ± radiation are not curative. Dostarlimab is an anti–programmed cell death 1 (PD-1) … Webb19 dec. 2024 · The European Medicines Agency considered that the beneficial effects of Jemperli on endometrial cancer seem to last longer than with other treatments available … hillman sunglasses
RUBY: Dostarlimab plus chemo for Endometrial cancer
Webb25 maj 2024 · The RUBY trial was designed to evaluate the efficacy and safety of dostarlimab in combination with carboplatin-paclitaxel in recurrent or primary advanced … WebbEndometriecancer är en typ av livmoderscancer som uppstår ur endometriet, (livmoderslemhinnans yttersta lager av epitel). [1] Detta orsakas av en abnorm tillväxt av celler som har förmåga att invadera eller spridas till andra delar av kroppen. [2] Det första tecknet är ofta mellanblödningar som inte är kopplade till menstruation.Andra symptom … Webb27 mars 2024 · GSK plc (LSE/NYSE: GSK) today announced interim results from Part 1 of the RUBY/ENGOT-EN-6-NSGO/GOG3031 phase III trial investigating Jemperli … hillman super minx